MedTrace Logo

Safety and Performance Study of the ARGOS-IO (Intraocular) System in Patients With Primary Open Angle Glaucoma (POAG)

NCT02434692 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2024-12-12

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to evaluate the safety and performance of the ARGOS-IO system in patients with POAG and indicated cataract surgery.

Conditions

  • Primary Open Angle Glaucoma (POAG)

Interventions

DEVICE

ARGOS-IO system

Implantation of ARGOS-IO pressure sensor after IOL placement within the cataract surgical procedure on day 0 (V01)

Sponsors & Collaborators

  • Implandata Ophthalmic Products GmbH

    lead INDUSTRY

Principal Investigators

  • Hagen Thieme, Prof. · University Eye Clinic Magdeburg, Germany

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
40 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-07-09
Primary Completion
2017-04-11
Completion
2017-04-11

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02434692 on ClinicalTrials.gov